Background: Ghrelin is a 28-amino acid peptide hormone which is produced in various tissues such as the kidney. It is proposed that this hormone exerts a broad spectrum of biological functions throughout the body. Ghrelin carries out endocrine and/or paracrine functions in the kidney, which seems to be one of the target tissues of this hormone. Results regarding circulating ghrelin levels in chronic kidney disease (CKD) and diabetic nephropathy (DN) patients are conflicting. We aimed to investigate the plasma ghrelin levels in type 2 diabetic patients with and without nephropathy. Methods: A total of 45 patients with DN and 45 patients with diabetes without diabetic nephropathy (NDN) were recruited for this study. Plasma ghrelin levels were determined using the enzyme-linked immunosorbent assay (ELISA) method. The association of plasma ghrelin with concentrations of fasting glucose (FBS), creatinine (Cr), blood urea nitrogen (BUN), low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), triglycerides (TG) and anthropometric parameters was analyzed. Results: Plasma ghrelin concentration in the DN group was 1.16 (1.01-1.38) ng/mL and in the NDN group was 1.16 (0.92-1.41) ng/mL, so there were no significant differences
Introduction
Ghrelin, a 28-amino-acid peptide hormone, is mostly produced by the stomach. In the beginning, it was recognized as the endogenous agonist of the growth hormone secretagogue receptor 1a (GHS-R1a), as it has a strong stimulatory effect on secretion of growth hormone (GH) and shows an appetite-stimulating effect [1] .
Based on recent studies, ghrelin seems to have other functions such as the control of metabolic, reproductive, immunologic and behavioral processes and gastrointestinal motility [1] . Furthermore, numerous studies have indicated that ghrelin may have a role in thyroid dysfunction [2] , glucose homeostasis [3] and microangiopathy [4] .
In addition to the production of ghrelin in the stomach, it has been demonstrated that this hormone is produced by the kidney and also the ghrelin receptor gene is expressed in the kidney [5] . This finding implies that ghrelin carries out endocrine and/or paracrine functions in the kidney, which seems to be one of the target tissues of this hormone [5] . This suggests that ghrelin contributes to the renal physiology.
There are several studies indicating that ghrelin may play a role in kidney function. Studies on rats have shown that ghrelin has a strong anti-inflammatory effect and can attenuate endothelial function in renal damage [6] and it is a potent antifibrotic agent in rat kidney [7] . Many studies have explored plasma ghrelin concentration in chronic kidney disease (CKD). Inconsistent results regarding the plasma ghrelin level in these patients have been reported. Results obtained by some studies indicate that plasma ghrelin concentration is higher in patients with renal failure [8] [9] [10] [11] [12] whereas Szczepanska et al. [13] reported that plasma ghrelin concentration is not statistically different between CKD children on dialysis, children on conservative treatment and healthy controls. Another study showed that adult patients on hemodialysis had a significantly lower serum ghrelin level than predialysis CKD patients [14] .
Diabetic nephropathy (DN) is the most prevalent microvascular complication in diabetic patients and a major cause of end-stage kidney disease [15] . A study on rats suggested that increased levels of ghrelin in diabetes may participate in the development of renal failure [16] . Also, it was proposed that ghrelin levels in type 2 diabetes can probably be an indication of renal dysfunction [17] . However, the precise role of ghrelin in renal dysfunction remains unclear.
So far, limited studies have been conducted regarding plasma ghrelin level in DN. Ueno et al. [4] indicated that in patients with DN and high levels of serum creatinine (Cr), plasma ghrelin concentration was significantly higher than in patients with normal levels of Cr. In another investigation, plasma ghrelin levels were similar in hemodialysis patients with and without diabetes mellitus [18] .
Therefore, we aimed to investigate the association of plasma ghrelin with DN by comparing the plasma ghrelin level in type 2 diabetic patients with and without DN. [19] .
Materials and methods

Subjects
The type 2 diabetic patients were subdivided into diabetics with DN and diabetics without diabetic nephropathy (NDN). The NDN group (n = 45, 18 men, 27 women) consisted of patients who had been diagnosed with diabetes for at least 5 years, with an absence of albuminuria [urinary albumin excretion rate (UAER) <30 mg/L]. The DN group (n = 45, 30 men, 15 women) had micro-albuminuria and overt albuminuria, defined as UAER > 30 mg/L.
As a marker of renal function, we used the estimated glomerular filtration rate (eGFR) calculated using the modification of diet in renal disease (MDRD) formula [20, 21] . Based on eGFR, the DN group was further categorized into five stages [22] Baseline demographic data such as height, weight, age, diabetes duration, history of coronary artery disease (CAD), hypertension (HTN) and smoking were obtained from the participants. Consent forms were obtained from all patients.
Methods
Blood samples were collected from the patients after 12-h fasting and were transferred into test tubes containing ethylenediaminetetraacetic acid (EDTA) and anti-protease. After centrifugation at 1000 g for 10 min, the plasma aliquot was frozen at −70 °C. Urinary albumin was measured using the micro-albumin enzyme-linked immunosorbent assay (ELISA) kit (DRG International Inc., NJ, USA).
Concentrations of fasting glucose (FBS), triglycerides (TG), low-density lipoprotein cholesterol (LDL), highdensity lipoprotein cholesterol (HDL), blood urea nitrogen (BUN) and Cr were measured by a spectrophotometric assay using routine laboratory methods by relevant biochemical kits (Parsazmun, Tehran, Iran).
For assessment of total plasma ghrelin levels, the ELISA method (Human Ghrelin Elisa Kit, ZellBio GmbH, Ulm, Germany) was used. The assay sensitivity was 0.01 ng/mL and the assay range was between 0.4 ng/mL and 12.8 ng/mL. Intra-assay and inter-assay variations of the kit to measure ghrelin were less than 10% and 12%, respectively.
Statistical analysis
SPSS version 15.0 software (Chicago, IL, USA) was used for analysis. Results are expressed as mean ± standard deviation (SD) for normally distributed data and as median (interquartile range) for nonparametric data. Adjustment to the normal distribution was analyzed using the Kolmogorov-Smirnov test. Statistical analysis of categorical variables was performed using the χ 2 -test. To evaluate the differences between the mean values of the variables with a normal distribution, independent samples t-test was used. Also, the Mann-Whitney U-test was applied for nonparametric data. The correlation coefficients between the varia bles were computed using Spearman's coefficient. Values of p < 0.05 were considered significant.
Results
Comparison of laboratory and anthropometric parameters of the two groups NDN and DN is given in Table 1 .
As expected, plasma Cr levels [132. 6 (79.56-194 .48) μmol/L vs. 61.88 (61.88-79.56) μmol/L, p = 0.000] and BUN levels (11.17 ± 4.46 mmol/L vs. 6.74 ± 2.21 mmol/L, p = 0.000) were significantly higher in the DN group compared to the NDN group. As shown in Table 1 , there was a significant difference in age between the DN and NDN groups (65.22 ± 11.07 vs. 59.86 ± 9.66, p = 0.013).
Plasma ghrelin concentration in the DN group was 1.16 (1.01-1.38) ng/mL and in the NDN group was 1.16 (0.92-1.42) ng/mL (p = 0.467). Furthermore, stratification of the DN group into the DN group with Cr level >120 μmol/L and DN group with Cr level <120 μmol/L and comparison of these two subgroups with the NDN group using the Kruskal-Wallis test showed no significant difference in the plasma ghrelin concentration (p = 0.765). Moreover, plasma ghrelin levels were compared between different stages of nephropathy using the Kruskal-Wallis test, which showed no significant difference (p = 0.241).
Using Spearman's correlation coefficient, the correlation of plasma ghrelin level with other variables was examined ( Table 2 ). As given in Table 2 , there was a significant inverse correlation between plasma ghrelin concentration and TG (r = −0.312, p = 0.003) and a significant positive correlation between plasma ghrelin and HDL (r = 0.266, p = 0.011) in our total population (DN and NDN).
In the NDN group, ghrelin was inversely correlated with TG (r = −0.467, p =0.001) and directly correlated with HDL (r = 0.562, p = 0.000), but in the DN group these correlations were not found. In addition, age correlated significantly with plasma ghrelin levels (r = 0.236, p = 0.025) in our total population and in the NDN group, whereas other parameters such as Cr, BUN, FBS, body mass index (BMI) and duration of diabetes did not show any significant correlation with plasma ghrelin levels. Using the Mann-Whitney U-test, plasma ghrelin levels did not show any significant correlation with CAD, HTN and smoking.
Discussion
In this study, we examined the relationship between plasma ghrelin level and DN. The main finding of our study was that there was no statistically significant difference in the plasma ghrelin concentration between diabetic patients with and without nephropathy.
Consistent with the result obtained by Ueno et al. [4] , in our study, the plasma level of ghrelin indicated no significant difference between the DN group with Cr < 120 μmol/L and the NDN group; but unlike the study by Ueno et al. in our study the ghrelin plasma levels did not show any significant difference between the DN group with Cr > 120 μmol/L and the DN group with Cr < 120 μmol/L. This inconsistency could perhaps be the result of the difference in the number of patients in the DN group with Cr higher than 120 μmol/L. In our study, 22 patients were in this group, while in the study by Ueno et al., only seven patients were in the group with Cr > 120 μmol/L. This difference may influence the statistical analysis. In addition, our findings indicated that there are no significant differences in the plasma ghrelin level at different stages of DN.
Firczyk et al. [18] observed that the fasting ghrelin level shows no significant difference in DN patients undergoing hemodialysis and hemodialysis patients without diabetes, but in both hemodialysis groups the fasting plasma ghrelin concentrations were significantly higher than in the control group. However, Tentolouris et al. [11] showed that in patients with renal failure (patients with and without diabetes) fasting plasma total ghrelin levels are higher when compared to healthy subjects. Furthermore, they showed that the cause of nephropathy does not have any effect on the ghrelin level. The results of the two above-mentioned studies are in line with our findings that DN does not have any effect on the plasma ghrelin level. Our results are not consistent with the hypothesis of Ma et al. [17] , that ghrelin concentration is a probable indicator of kidney insufficiency in patients with T2DM.
Based on our results, ghrelin levels showed a significant positive correlation with age. The positive correlation between age and ghrelin in our study is inconsistent with other studies which showed a negative correlation between age and plasma ghrelin [9, 23] .
Previous studies have shown a direct correlation between total ghrelin and HDL, and an inverse correlation with TG [23] [24] [25] . In agreement with these data, we also observed a direct relationship between ghrelin and HDL levels and an inverse correlation with TG in our total population and in diabetic patients without renal failure. However, these correlations were not found in the DN patients (DN group). A possible explanation for this observation could be the larger number of males than females in the DN group and the fact that the HDL level is affected by gender. It is proposed that there is a particular interaction between ghrelin and HDL, suggesting that HDL particles probably act as circulating transporters of ghrelin [26, 27] .
In this study, plasma ghrelin values are lower compared to other studies which mostly used the radioimmunoassay (RIA) technique for measurement of ghrelin. Differences in plasma ghrelin levels in limited studies regarding DN may be due to different characteristics of the patients being studied such as disease stage, illness duration or treatment strategies. Furthermore, the differences could be the result of differences in measurement methods. Some studies also suggested that ghrelin assays with different methodologies have dissimilar results [28, 29] . Prudom et al. [29] showed that acyl and desacyl ghrelin values obtained using the sandwich ELISA method are lower than those obtained by the RIAs. They suggested that "single-site assays (in RIA) can be less specific as a result of interference from peptide fragments or cross-reactivity at a single epitope, whereas sandwich assays require recognition of two epitopes using two different antisera, thus eliminating many interferences and lowering nonspecific background" [29] .
In our study, only TG and HDL as parameters of metabolic syndrome showed a correlation with ghrelin in diabetics. However, to claim parameters of metabolic syndrome as independent regulators of ghrelin by a simple correlation test is not adequate and further analysis is required. Therefore, the identification of major regulators of ghrelin in T2DM needs more investigation.
Due to the existing limitations, we did not measure any inflammatory biomarkers. Moreover, we only assessed total ghrelin concentrations, whereas circulating ghrelin is present in two main forms as acylated (<10%) and desacyl ghrelin [30] . Perhaps, measurement of inflammatory biomarkers and of these two forms of ghrelin could be helpful in better understanding the role of ghrelin in renal dysfunction.
Conclusions
Our findings implicate that there is no association between plasma ghrelin levels and renal dysfunction in type 2 diabetic patients. Therefore, the plasma ghrelin level may not be a probable indicator of kidney insufficiency in patients with T2DM. Furthermore, we also found a direct correlation between ghrelin and HDL and an inverse correlation with TG levels.
